Quantitative metabolomics services for biomarker discovery and validation.
Specializing in ready to use metabolomics kits.
Your source for quantitative metabolomics technologies and bioinformatics.
Loader

Filter by Species:

Filter by Pathway Type:

Select Pathway Sub-Category:

Select Pathway Sub-Category:


Search for '28cortisol oh aldosterone 20 and subjected 3ametabolic' in 'all pathways' in 'all' returned 517568 results

SMP0646237

Pw686582 View Pathway
Metabolite

L-Cysteine Degradation

Helicobacter canadensis MIT 98-5491

  • Matched Description: in the release of a hydrogen sulfide, a hydrogen ion and a a 2-aminoprop-2-enoate. The latter … spontaneously with water and a hydrogen ion resulting in the release of ammonium and pyruvate.

  • Metabolic

    SMP0502620

    Pw528564 View Pathway
    Metabolite

    L-Cysteine Degradation

    Citrobacter amalonaticus Y19

  • Matched Description: in the release of a hydrogen sulfide, a hydrogen ion and a a 2-aminoprop-2-enoate. The latter … spontaneously with water and a hydrogen ion resulting in the release of ammonium and pyruvate.

  • Metabolic

    SMP0503226

    Pw529271 View Pathway
    Metabolite

    L-Cysteine Degradation

    Acinetobacter junii SH205

  • Matched Description: in the release of a hydrogen sulfide, a hydrogen ion and a a 2-aminoprop-2-enoate. The latter … spontaneously with water and a hydrogen ion resulting in the release of ammonium and pyruvate.

  • Metabolic

    SMP0503095

    Pw529125 View Pathway
    Metabolite

    L-Cysteine Degradation

    Plesiomonas shigelloides 302-73

  • Matched Description: in the release of a hydrogen sulfide, a hydrogen ion and a a 2-aminoprop-2-enoate. The latter … spontaneously with water and a hydrogen ion resulting in the release of ammonium and pyruvate.

  • Metabolic

    SMP0503881

    Pw530021 View Pathway
    Metabolite

    L-Cysteine Degradation

    Halococcus morrhuae DSM 1307

  • Matched Description: in the release of a hydrogen sulfide, a hydrogen ion and a a 2-aminoprop-2-enoate. The latter … spontaneously with water and a hydrogen ion resulting in the release of ammonium and pyruvate.

  • Metabolic

    SMP0058891

    Pw059823 View Pathway
    Metabolite

    Clemastine H1-Antihistamine Immune Response Action Pathway

    Homo sapiens

  • Matched Description: the agonist action of histamine at the H1 receptor and are administered to attenuate inflammatory … process in order to treat conditions such as allergic rhinitis, allergic conjunctivitis, and urticaria … constrict dilated blood vessels, and in smooth muscles of lungs and intestines to relax those … muscles. Allergies causes blood vessel dilation which causes swelling (edema) and fluid leakage … . Reducing the activity of the NF-κB immune response transcription factor through the phospholipase C and

  • Drug Action

    SMP0000553

    Pw000529 View Pathway
    Metabolite

    Glycogenosis, Type III. Cori Disease, Debrancher Glycogenosis

    Homo sapiens

  • Matched Description: of GSD-III is higher in North African Jews (1 in 5 400), Faroese (1 in 3 100) and the Inuit … is structurally abnormal and impairs the function of certain organs and tissues, especially the … liver and muscles. GSD III typically presents during infancy with hypoglycemia and failure to thrive … . Clinical examination usually reveals hepatomegaly. Muscular disease, including hypotonia and … cardiomyopathy, usually occurs later in life. GSD III is divided into the types IIIa, IIIb, IIIc, and IIId

  • Disease

    SMP0126770

    Pw128374 View Pathway
    Metabolite

    Omadacycline Action Pathway

    Homo sapiens

  • Matched Description: pneumonia. It acts by binding to the 30S ribosomal subunit blocking protein synthesis and disrupting … bacterial function leading to cell death. Omadacycline should be taken on an empty stomach and … multivalent ions and antacids should be avoided whilst taking omadacycline.

  • Drug Action

    SMP0126839

    Pw128444 View Pathway
    Metabolite

    Coagulation Factor VII Human Action Pathway

    Homo sapiens

  • Matched Description: Coagulation factor VII human is a coagulation factor also known as Balfaxar, Beriplex, Kcentra and … Octaplex to treat hemophilia and Glanzmann's thrombasthenia. It is administered intravenously it … subsequently activate coagulation factor X and IX leading to blood clotting formation. It is broken down via catabolism in the body.

  • Drug Action

    SMP0120836

    Pw122097 View Pathway
    Metabolite

    Glycogenosis, Type III. Cori Disease, Debrancher Glycogenosis

    Rattus norvegicus

  • Matched Description: of GSD-III is higher in North African Jews (1 in 5 400), Faroese (1 in 3 100) and the Inuit … is structurally abnormal and impairs the function of certain organs and tissues, especially the … liver and muscles. GSD III typically presents during infancy with hypoglycemia and failure to thrive … . Clinical examination usually reveals hepatomegaly. Muscular disease, including hypotonia and … cardiomyopathy, usually occurs later in life. GSD III is divided into the types IIIa, IIIb, IIIc, and IIId

  • Disease